Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Alexandra Noveihed
Institutions:
Rutgers, The State University of New Jersey,
Rutgers Cancer Institute
Observed institutions:
Rutgers, The State University of New Jersey,
Abramson Cancer Center,
Rutgers Health,
Rutgers Cancer Institute,
University of Pennsylvania
ORCID:
0000-0002-0024-537X
Observed ORCID:
0000-0002-0024-537X
OpenAlex ID:
A5025486526
Ovarian Suppression: Early Menopause, Late Effects
2024
·
Chaya Goldberg
, Megan R. Greenberg
, et al.
·
Current Oncology Reports
·
9
Bispecific antibody therapy in CNS myeloma: Early evidence from a multicentre cohort
2025
·
Alexandra Noveihed
, Samer Al Hadidi
, et al.
·
British Journal of Haematology
·
8
PDF
Hemophagocytic lymphohistiocytosis: a rare disease unveiling the diagnosis of EBV-related large B cell lymphoma in a patient with HIV
2022
·
Alexandra Noveihed
, Shiochee Liang
, et al.
·
Discover Oncology
·
7
PDF
Impact of sequencing of CART vs bi-specific antibody on survival in relapsed/refractory large B-cell lymphoma: An analysis from the ABC consortium
2025
·
Max Kelsten
, Colin Thomas
, et al.
·
Blood
·
3
PDF
Overview of ocular toxicities associated with breast cancer therapies
2025
·
Megan R. Greenberg
, Alexandra Noveihed
, et al.
·
Breast Cancer Research and Treatment
·
2
Bispecific antibody therapy in central nervous system (CNS) multiple myeloma (MM): Multicenter retrospective study.
2025
·
Alexandra Noveihed
, Samer Al Hadidi
, et al.
·
Journal of Clinical Oncology
·
2
Risk factors for CRS and ICANS with bispecific antibodies for aggressive lymphomas
2026
·
Victoria Gill
, Thomas Ollila
, et al.
·
Blood Advances
·
1
PDF
Disparities in place of death from prostate cancer revealed by disaggregation of Asian race.
2022
·
Alexandra Noveihed
, Naveena Lall
, et al.
·
Journal of Clinical Oncology
·
1
Rethinking Surveillance: Low Incidence of Late-Onset Toxicities across CD-19 CAR T-cell Constructs Supports Reduced Monitoring
2026
·
Megan Melody
, Adit Dharia
, et al.
·
Transplantation and Cellular Therapy
Risk factors for CRS and NT with bispecific antibodies: Data from the American bispecifics and CART (ABC) consortium
2025
·
Victoria Gill
, Ari Pelcovits
, et al.
·
Blood
PDF
Real world comparison of commercial CAR T-cell constructs for the treatment of LBCL
2025
·
Megan Melody
, Alan Kerr
, et al.
·
Blood
HTRS2025.P2.65 Steroid Taper for Bullous Pemphigoid Unveiling Acquired Hemophilia A Secondary to Pembrolizumab Therapy for Metastatic Laryngeal Carcinoma: A Case Report
2025
·
Alexandra Noveihed
, Amanda Kaveney
·
Research and Practice in Thrombosis and Haemostasis
Abstract P1-10-25: Metachronous triple negative breast cancer in a young patient with aggressive presentation of metastatic HER2 positive breast cancer: treatment considerations and management
2025
·
Alexandra Noveihed
, Milagros Cappa
, et al.
·
Clinical Cancer Research
Abstract P6-05-32: Does Aggregation Hide Place of Death Disparities for Asians with Breast Cancer?
2023
·
Naveena Lall
, Alexandra Noveihed
, et al.
·
Cancer Research
Abstract P6-08-10: Cash, Commercial Negotiated Prices, and Correlations with Neighborhood Poverty Levels for Shoppable Breast Cancer Services
2023
·
Alexandra Noveihed
, Naveena Lall
, et al.
·
Cancer Research
Show more works
View as search
Works count:
15
Citation count:
33
H-index:
3
I10-index:
Year
Topic
Type